Guideline for the investigation and management of eosinophilia
The guideline group was selected to be representative of UK-based medical experts with an
interest in myeloproliferative neoplasms and eosinophilia. PubMed and EMBASE were …
interest in myeloproliferative neoplasms and eosinophilia. PubMed and EMBASE were …
Immunometabolism: an emerging target for immunotherapies to treat rheumatoid arthritis
An increasing number of findings highlight the fundamental role of metabolism in
autoimmunity. This growing recognition of metabolic irregularities being a factor of immune …
autoimmunity. This growing recognition of metabolic irregularities being a factor of immune …
Emerging role of eosinophils in resolution of arthritis
Y Qin, HZ Jin, YJ Li, Z Chen - Frontiers in immunology, 2021 - frontiersin.org
Eosinophils are a minor component of circulating granulocytes, which are classically viewed
as end-stage effector cells in host defense against helminth infection and promoting allergic …
as end-stage effector cells in host defense against helminth infection and promoting allergic …
Sonicate fluid cellularity predicted by transcriptomic deconvolution differentiates infectious from non-infectious arthroplasty failure
Background: Although cellularity is traditionally assessed morphologically, deep sequencing
approaches being used for microorganism detection may be able to provide information …
approaches being used for microorganism detection may be able to provide information …
Genetic evidence for causal effects of leukocyte counts on risk for rheumatoid arthritis
JM You, YC Zhang, KY Fan, SK Bai, ZY Zhang… - Scientific Reports, 2023 - nature.com
Rheumatoid arthritis (RA) is an autoimmune disease characterized by the accumulation of
leukocytes and inflammatory mediators within the synovial tissue. Leukocyte counts are …
leukocytes and inflammatory mediators within the synovial tissue. Leukocyte counts are …
Hypereosinophilic syndrome—a rare adverse event of anti-cytokine treatment in rheumatoid arthritis resolved after Janus kinase inhibitor therapy
E Šteňová, L Tarabčáková, P Babál, S Kašperová - Clinical Rheumatology, 2020 - Springer
Eosinophilia is uncommon in early rheumatoid arthritis (RA). The most frequent causes of
hypereosinophilia during RA treatment are atopic eczema, allergy, helminth infection …
hypereosinophilia during RA treatment are atopic eczema, allergy, helminth infection …
Anti-IL-5 biologics and rheumatoid arthritis: a single-centre 500 patient year exposure analysis
NJ Dean, IJ Clifton, R Salman, C Bridgewood… - RMD open, 2023 - rmdopen.bmj.com
Objective The increasing use of biological therapies has led to the paradoxical finding that
monoclonal antibody therapy for one inflammatory disease can sometimes induce another …
monoclonal antibody therapy for one inflammatory disease can sometimes induce another …
[HTML][HTML] Eosinophilia in rheumatoid arthritis patients and its relation to disease activity: a single center experience from Kashmir, India
F Sofi, A Parrey, M Ahmad - The Egyptian Rheumatologist, 2017 - Elsevier
Introduction Eosinophilia is reported in several rheumatic diseases including rheumatoid
arthritis (RA) and considered an indicator of high disease activity and a factor of poor …
arthritis (RA) and considered an indicator of high disease activity and a factor of poor …
Persistent eosinophilia in rheumatoid arthritis: a prospective observational study
Eosinophilia is an uncommon manifestation in Rheumatoid arthritis (RA), and there is a
paucity of data regarding the relationship of eosinophilia with disease-related factors. We …
paucity of data regarding the relationship of eosinophilia with disease-related factors. We …
类风湿关节炎滑膜组织中脯氨酸羟化酶及希佩尔林道肿瘤抑制蛋白的表达及意义
宋小莉， 苏娟， 刘重阳， 张广源， 张鑫 - 中国组织工程研究, 2019 - cjter.com
文章快速阅读: 文题释义: 希佩尔林道肿瘤抑制蛋白: 希佩尔林道病肿瘤抑制基因(Von Hippel-
lindau, VHL) 是位于3p25-26 号染色体的抑癌基因. VHL 蛋白开放阅读框架编码213 个氨基酸 …
lindau, VHL) 是位于3p25-26 号染色体的抑癌基因. VHL 蛋白开放阅读框架编码213 个氨基酸 …